Experiments led by researchers at the Department of Energy's Oak Ridge National Laboratory have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the ...
Nov 16, 2020
0
131
You're invited to join the search for COVID-19 treatments—no lab coat or Ph.D. necessary.
Oct 14, 2020
0
3
Healthcare workers who self-isolated after developing symptoms of COVID-19 were more likely to have a vitamin D deficiency, with workers from Black, Asian or ethnic minority backgrounds particularly affected, a new study ...
Oct 7, 2020
2
4148
Research by the University of Southampton has paved the way for experts in Birmingham to develop a new test to detect COVID-19 antibodies in people with recent exposure who have mild symptoms.
Aug 27, 2020
0
1
A team of scientists studying the origin of SARS-CoV-2, the virus that has caused the COVID-19 pandemic, found that it was especially well-suited to jump from animals to humans by shapeshifting as it gained the ability to ...
May 29, 2020
2
338
An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19.
May 18, 2020
3
3425
In December 2019, the world learned of a new and deadly pathogen. News coming out of Wuhan, China confirmed public health experts' worst fears—a novel coronavirus appeared to have jumped from animals to humans. It was extremely ...
May 11, 2020
0
2
As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers.
Apr 21, 2020
0
1
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway ...
Apr 20, 2020
0
1024
In preclinical experiments, University of Alabama at Birmingham researchers have revealed a key missing piece of the Alzheimer's disease puzzle. That allowed proof-of-concept experiments—using an existing drug—that dramatically ...
Jan 15, 2020
6
662
